New Age Alpha Advisors LLC Cuts Stock Holdings in Zoetis Inc. $ZTS

New Age Alpha Advisors LLC reduced its stake in shares of Zoetis Inc. (NYSE:ZTS) by 10.6% during the third quarter, Holdings Channel reports. The institutional investor owned 45,520 shares of the company’s stock after selling 5,370 shares during the quarter. New Age Alpha Advisors LLC’s holdings in Zoetis were worth $6,660,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Zoetis by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 42,306,764 shares of the company’s stock worth $6,190,326,000 after acquiring an additional 419,777 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Zoetis by 0.9% during the second quarter. Geode Capital Management LLC now owns 11,081,301 shares of the company’s stock valued at $1,721,356,000 after purchasing an additional 95,294 shares during the period. Norges Bank bought a new position in shares of Zoetis in the second quarter worth approximately $809,491,000. Brown Advisory Inc. grew its holdings in shares of Zoetis by 5.7% in the second quarter. Brown Advisory Inc. now owns 4,659,371 shares of the company’s stock worth $726,629,000 after purchasing an additional 250,829 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Zoetis by 14.6% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,312,779 shares of the company’s stock worth $631,046,000 after buying an additional 550,859 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ZTS shares. UBS Group set a $136.00 price target on shares of Zoetis in a research report on Thursday, January 29th. HSBC set a $140.00 target price on shares of Zoetis in a report on Wednesday, December 10th. Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Morgan Stanley set a $160.00 price objective on Zoetis in a report on Thursday, December 18th. Finally, BTIG Research reissued a “buy” rating and set a $160.00 target price on shares of Zoetis in a research note on Thursday. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $152.91.

Zoetis Stock Up 1.0%

ZTS stock opened at $131.06 on Friday. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.00. The company has a market capitalization of $55.32 billion, a price-to-earnings ratio of 21.77, a price-to-earnings-growth ratio of 2.00 and a beta of 0.96. The business’s 50 day moving average price is $126.05 and its two-hundred day moving average price is $134.05. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03.

Zoetis (NYSE:ZTS) last released its earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. During the same quarter last year, the business posted $1.40 EPS. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Monday, April 20th. Zoetis’s payout ratio is 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.